Acid reflux (GERD) occurs when stomach acid flows back into the esophagus due to a weakened lower esophageal sphincter. Proton pump inhibitors (PPIs) such as omeprazole and pantoprazole are the most effective medications for moderate-to-severe GERD and erosive esophagitis. H2 blockers (famotidine/Pepcid) provide faster, milder relief and are appropriate for intermittent heartburn and milder cases.
Acid Reflux & GERD: Medications, Treatment & Drug Guide
Acid reflux — and its chronic form, gastroesophageal reflux disease (GERD) — is one of the most prevalent gastrointestinal conditions worldwide, affecting an estimated 18–28% of adults in North America. It occurs when the lower esophageal sphincter (LES), the muscular valve between the esophagus and stomach, fails to close properly, allowing stomach acid and digestive contents to flow upward into the esophageal lining, which is not designed to withstand acid exposure.
The result ranges from occasional heartburn — the familiar burning sensation behind the breastbone — to more serious complications including esophageal inflammation (esophagitis), bleeding, Barrett's esophagus (a pre-cancerous change in the esophageal lining), and esophageal stricture. Treatment aims to reduce acid exposure, relieve symptoms, heal existing inflammation, and prevent complications.
Overview: GERD vs Heartburn vs LPR
Heartburn
Heartburn is a symptom — the burning sensation in the chest or throat caused by acid contact with the esophageal lining. It is the most common symptom of acid reflux but not the only one. Occasional heartburn, particularly after large meals or fatty/spicy foods, is very common and does not necessarily indicate GERD. Persistent, frequent heartburn (more than twice per week) warrants evaluation for GERD.
GERD (Gastroesophageal Reflux Disease)
GERD is a chronic condition defined by reflux occurring frequently enough to cause bothersome symptoms or complications. Beyond heartburn, GERD symptoms include regurgitation (the sensation of acid or food coming up into the throat), difficulty swallowing, chest pain (that can mimic cardiac pain and warrants evaluation), chronic hoarseness, and chronic cough. Lifestyle modifications — weight loss if overweight, elevation of the head of the bed, avoiding trigger foods, not lying down within two to three hours of eating — are foundational for all patients.
LPR (Laryngopharyngeal Reflux)
LPR, sometimes called "silent reflux," occurs when stomach acid reaches the larynx and pharynx. Unlike classic GERD, patients with LPR may not experience prominent heartburn but instead present with chronic throat clearing, hoarseness, a lump-in-throat sensation (globus), or chronic cough. It can be harder to diagnose and treat than classic GERD. PPIs are the primary medical treatment but may require longer courses than for standard GERD.
H2 Blockers vs Proton Pump Inhibitors: When Each Is Appropriate
H2 blockers (famotidine) are appropriate for: intermittent, mild heartburn; on-demand or pre-meal use; patients who need quick relief; and those at lower risk of complications. PPIs (omeprazole, pantoprazole) are appropriate for: moderate-to-severe or frequent GERD; erosive esophagitis; Barrett's esophagus; peptic ulcer disease; and H. pylori eradication regimens. PPIs are more potent but take longer to reach full effect and work best taken consistently before meals rather than on-demand.
First-Line Medications
About the Medications
Omeprazole (Prilosec) was the first proton pump inhibitor and remains one of the most widely used. It is available both over-the-counter and by prescription, making it accessible for self-managed heartburn. PPIs work by irreversibly binding to and inhibiting the hydrogen-potassium ATPase enzyme (the proton pump) in the stomach's acid-secreting parietal cells. Because PPIs bind only to actively secreting pumps, they are most effective when taken 30–60 minutes before a meal, when the pumps are most active. Omeprazole is metabolized by CYP2C19, and genetic variation in this enzyme affects how rapidly different patients clear the drug.
Pantoprazole (Protonix) is another PPI with a similar mechanism to omeprazole. It is often preferred in hospitalized patients due to its availability in intravenous form and is also used long-term for maintenance of erosive esophagitis and GERD. Pantoprazole has fewer CYP-mediated drug interactions than omeprazole, which can be an advantage in patients on multiple medications. It is available by prescription and, more recently, over the counter.
Famotidine (Pepcid) is an H2 blocker — it reduces acid secretion by blocking histamine H2 receptors on parietal cells, which is one of the three pathways that drive acid production. Famotidine acts faster than PPIs (onset within 1–3 hours vs. up to 4 days for full PPI effect), making it well-suited for on-demand relief and prevention of anticipated reflux (before a known trigger meal). It does not require timing relative to meals the way PPIs do. For patients with mild-to-moderate GERD or intermittent heartburn, famotidine may be all that is needed.
Ranitidine (Zantac) — withdrawn: Ranitidine was a widely used H2 blocker that was voluntarily recalled and then formally withdrawn from the US market by the FDA in April 2020. Testing revealed that ranitidine molecules are inherently unstable and generate NDMA (N-nitrosodimethylamine) — a probable human carcinogen — especially when stored at high temperatures or over time. The NDMA contamination was an intrinsic property of the ranitidine compound itself, not a manufacturing defect. Famotidine (Pepcid) is the recommended replacement and does not have the same stability issue.
Other Medications for Acid Reflux
- Antacids (calcium carbonate, aluminum/magnesium hydroxide — Tums, Rolaids, Maalox) — Provide rapid but short-lived neutralization of existing stomach acid; no acid reduction. Useful for immediate, occasional symptom relief.
- Esomeprazole (Nexium) — PPI; the S-isomer of omeprazole with a slightly different metabolic profile and longer half-life for some patients.
- Lansoprazole (Prevacid) — PPI available OTC and by prescription.
- Alginate-based agents (Gaviscon) — Form a physical raft on top of stomach contents to physically block reflux; useful adjunct for postprandial reflux.
- Baclofen — Used off-label to reduce transient lower esophageal sphincter relaxations in refractory GERD; generally reserved for specialist use.
Drug Classes Used
The PPI class includes omeprazole, esomeprazole, pantoprazole, lansoprazole, dexlansoprazole, and rabeprazole. All share the same mechanism — irreversible inhibition of the parietal cell proton pump — but differ in pharmacokinetics, drug interactions, and specific approved indications. The choice between PPIs is often driven by formulary availability, cost, and interaction profiles rather than large differences in efficacy.
H2 blockers (famotidine, cimetidine) form a distinct, older class. Cimetidine, the first H2 blocker, is now less preferred due to a wide range of drug interactions from CYP enzyme inhibition; famotidine is the preferred H2 blocker in current practice.
Common Drug Interactions
A critically important concept with acid reflux medications is absorption interference. Many medications depend on an acidic stomach environment for optimal absorption. When PPIs or H2 blockers raise gastric pH significantly, they can impair the absorption of drugs and nutrients that require acidity to dissolve properly.
Antacids and PPIs interfere with ciprofloxacin (and other fluoroquinolone antibiotics) absorption by chelating the drug — the metal ions in antacids (calcium, magnesium, aluminum) bind to the antibiotic molecule in the stomach, forming an insoluble complex that cannot be absorbed. This can substantially reduce antibiotic effectiveness. Ciprofloxacin should be taken at least two hours before or six hours after antacids.
Levothyroxine (thyroid hormone replacement) absorption is highly sensitive to co-administered substances. Calcium supplements, antacids, iron supplements, PPIs, and food can all reduce levothyroxine absorption if taken at the same time. Levothyroxine is typically taken on an empty stomach, well separated from other medications and supplements, to ensure consistent thyroid levels.
Other notable acid-suppression interactions include: PPIs and clopidogrel (omeprazole and esomeprazole inhibit CYP2C19, reducing activation of the antiplatelet drug clopidogrel — pantoprazole is preferred when a PPI is needed alongside clopidogrel), PPIs and methotrexate (PPIs may raise methotrexate levels), and PPIs reducing absorption of itraconazole, ketoconazole, and some HIV medications that require acidity for dissolution.
Side Effects to Watch For
Short-term PPI side effects are generally mild: headache, diarrhea, nausea, and abdominal pain. Long-term PPI use (particularly years of continuous use) has been associated in observational studies with magnesium deficiency, reduced calcium and B12 absorption, increased risk of Clostridioides difficile colitis, hypomagnesemia, and potential kidney effects. Many patients continue PPIs beyond when they are needed — periodic evaluation of whether ongoing therapy is still indicated is appropriate for most patients. H2 blockers have a more favorable long-term safety profile but are less effective for erosive or complicated GERD.
Comparing H2 Blockers and PPIs
Choosing between H2 blockers and PPIs involves weighing speed of onset, potency, and risk profile:
- Speed of onset: H2 blockers act within 1–3 hours; PPIs take 1–4 days of consistent use to reach full acid suppression (because they require active proton pumps, and the full population of pumps is only activated over multiple dosing cycles).
- Potency: PPIs suppress acid production more completely — reducing acid output by 80–95% compared to 60–70% with H2 blockers.
- Healing efficacy: For erosive esophagitis (visible damage to the esophageal lining), PPIs have significantly higher healing rates than H2 blockers.
- Tolerance: Tolerance to H2 blockers can develop with continuous use. PPIs maintain consistent efficacy without tolerance.
- Long-term risk: H2 blockers have a more favorable long-term safety profile; PPIs carry the nutrient absorption and infection concerns with very long-term use.
- Best use: H2 blockers for intermittent, mild heartburn; PPIs for established GERD, erosive esophagitis, Barrett's esophagus, and peptic ulcer disease.
Frequently Asked Questions
What is the difference between heartburn, acid reflux, and GERD?
Heartburn is the burning chest sensation caused by stomach acid irritating the esophageal lining — it is a symptom, not a diagnosis. Acid reflux is the underlying mechanism: stomach contents flowing backward into the esophagus. GERD (gastroesophageal reflux disease) is the chronic condition defined by acid reflux occurring frequently enough to cause bothersome symptoms or complications. Occasional heartburn is common; GERD implies a persistent pattern requiring evaluation and treatment.
What is the difference between H2 blockers and proton pump inhibitors (PPIs)?
H2 blockers (famotidine) reduce acid by blocking one of three signals that drive acid secretion. They work within 1–3 hours and suit on-demand heartburn relief and milder GERD. PPIs (omeprazole, pantoprazole) block the final step of acid production and are more potent and longer-acting. PPIs are the drug of choice for healing erosive esophagitis, treating moderate-to-severe GERD, and preventing ulcer recurrence — but require consistent daily use before meals to achieve maximum effect.
Why was ranitidine (Zantac) recalled?
Ranitidine (Zantac) was withdrawn from the US market by the FDA in April 2020 following the discovery that the drug generates NDMA — a probable human carcinogen — that increases over time and with storage at elevated temperatures. The NDMA contamination was intrinsic to the ranitidine molecule itself. Famotidine (Pepcid) is a safe alternative H2 blocker that does not have the same stability issue.
Are PPIs safe for long-term use?
PPIs are generally well tolerated for short-to-medium-term use. Long-term use (years) is associated in observational studies with magnesium and B12 deficiency, reduced calcium absorption, and increased risk of C. difficile infection. These risks must be balanced against benefits for patients with serious GERD complications. Many patients are prescribed PPIs longer than necessary — periodic reassessment of ongoing need is appropriate.
⚠ This article is for informational purposes only and does not constitute medical advice. Chest pain can have cardiac causes — seek immediate evaluation if you experience new, severe, or crushing chest pain. Always discuss GERD symptoms and medication choices with a qualified healthcare provider.